ClinicalTrials.Veeva

Menu

Preventing Acute Kidney Injury

Atlantic Health System logo

Atlantic Health System

Status

Withdrawn

Conditions

Acute Kidney Injury

Treatments

Other: remote ischemic preconditioning
Other: KDIGO guidelines

Study type

Interventional

Funder types

Other

Identifiers

NCT04376619
1527104-1

Details and patient eligibility

About

Acute kidney injury increases the risk for chronic kidney disease, length of stay, readmissions and mortality. Currently the only way to diagnose acute kidney injury is with a serum creatinine or drop in urine output. Biomarkers for acute kidney injury are well elevated before rise in creatinine. Hypothesis is that by implementing an electronic alert system with an algorithm followed by remote ischemic preconditioning will prevent acute kidney injury.

Full description

The propose study is to incorporate an alert system in current medical health system and an algorithm will be used to activate clinicians and Nephrologist to confirm if patient is at high risk. Once identified as high risk the clinician and/or nephrologist will intervene and change current management if needed. First phase of study will look at an alert system and algorithm was enough to lower incidence of acute kidney injury. Phase 2 will also use alert system and algorithm that will be further randomized those that are identified as high risk for acute kidney injury to remote ischemic preconditioning.

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • any admitted patients that are not excluded by exclusion criteria
  • Patients who's creatinine returns to baseline after admitted can be included in study if patient still remains admitted.

Exclusion criteria

  • End stage renal disease
  • estimated glomerular filtration rate less then 20
  • Left ventricular assist device patients
  • observation status
  • hospice patients
  • pregnancy
  • age less then 18
  • acute kidney injury on admission defined as 1.5 times elevated creatinine prior to last admission's creatinine
  • nephrology consult already placed
  • renal transplant or nephrectomy within 1 year
  • Patients unable to provide consent

exclusion for remote ischemic preconditioning in addition to above exclusion will be:

  • symptoms or diagnosis of peripheral arterial disease
  • Patients in shock defined by requiring inotropes or vasopressors

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

0 participants in 2 patient groups

KDIGO guidelines
Experimental group
Description:
Part 1 of study, those identified as high risk for AKI then will have Kidney Disease Global Improving outcomes guideline implemented to see if this reduces incidence of AKI
Treatment:
Other: KDIGO guidelines
RIPC
Experimental group
Description:
part 2 of study, those identified as high risk of AKI will have Kidney Disease Improving Global Outcomes guidelines and RIPC implemented to see if this reduces incidence of AKI compared to part 2 of study
Treatment:
Other: remote ischemic preconditioning

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems